Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
PR Newswire•26/10/2026•08:00 ET
0
Key Highlights
- ➤Evogene (EVGN) will attend BIO-Europe in Cologne, November 9-11, 2026
- ➤Evogene will seek partnerships in AI-driven small-molecule discovery and development
- ➤Evogene will present its ChemPass AI™ platform at Barcelona’s Drug Discovery Chemistry Europe
- ➤ChemPass AI™ covers virtual screening, QSAR-driven hit-to-lead, and de novo molecular design
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain PR Newswire
Company to Attend BIO-Europe in Cologne, Germany, and Present a Scientific Poster at Drug Discovery Chemistry Europe in Barcelona, Spain
Get started
Create a free account to read the full story.